Hormone Excretion in Prostatic Cancer
Author Information
Author(s): R. D. Bulbrook, L. M. Franks, F. C. Greenwood
Primary Institution: Clinico-pathological Laboratories, Imperial Cancer Research Fund
Hypothesis
The study attempts to correlate urinary hormone excretion with the clinical state of prostatic cancer patients undergoing treatment.
Conclusion
The urinary excretion of hormones is depressed by treatment, but often rises back to pre-treatment levels, which is associated with renewed tumor growth.
Supporting Evidence
- The study measured hormone excretion in 8 patients with prostatic cancer before and during treatment.
- Results showed a biphasic response in hormone levels, with initial decreases followed by increases.
- Clinical improvement was often associated with lower hormone excretion.
Takeaway
Doctors looked at how hormones in urine changed in men with prostate cancer after they got treatment, and found that hormone levels often went down but then came back up, which could mean the cancer was growing again.
Methodology
The study involved collecting 24-hour urine specimens from patients before and during treatment, and assessing clinical states without knowledge of biochemical findings.
Potential Biases
There may be unconscious selection of cases and variability in patient responses to treatment.
Limitations
The study had a small sample size and potential selection bias, as severely ill patients were excluded.
Participant Demographics
Patients aged 66 to 80 years with prostatic cancer.
Want to read the original?
Access the complete publication on the publisher's website